Looking to publish in The Pharmacogenomics Journal? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginThe Pharmacogenomics Journal is a Nature journal focused on pharmacogenomics research and publishes article formats including Articles, Review Articles, and Perspectives.
Looking to publish in The Pharmacogenomics Journal? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
The Pharmacogenomics Journal accepts the following article types. Click on an article type to view submission instructions.
Article
Review Article
Correspondence
Perspective
Recent Publications
Association between CYP2D6 genotype and treatment effectiveness and safety in 99 hospitalized patients with major depressive disorder a retrospective cohort study CYP2D6 genotype and antidepressant response
Aleksandra Petković Ćurčin, Aleksandra Jeremić, Danilo Joković, Gordana Šupić, Katarina Simić, Filip Milosavljević, Zvezdana Stojanović, Marin M. Jukić
Large-scale analysis demonstrates the influence of CYP2C19 genotype on specific SSRI side effects
Chris Eijsbouts, Yunxuan Jiang, James R. Ashenhurst, Julie M. Granka, Stella Aslibekyan, Robert K. Bell, Zayn Cochinwala, Sayantan Das, Kahsaia de Brito, Emily DelloRusso, Devika Dhamija, Payam Dibaeinia, Sarah L. Elson, Nicholas Eriksson, Shirin Fuller, Chris German, Larry Hengl, Barry Hicks, David A. Hinds, Michael V. Holmes, M. Reza Jabalameli, Ethan M. Jewett, Matt Kmiecik, Katelyn Kukar Bond, Alan Kwong, Keng-Han Lin, Yanyu Liang, Aly Khan, Matthew H. McIntyre, Alex Moran, Carrie Northover, Jared O’Connell, Steve Pitts, Shubham Saini, Anjali J. Shastri, Jingchunzi Shi, Suyash Shringarpure, Teague Sterling, Qiaojuan Jane Su, Joyce Y. Tung, Vinh Tran, Xin Wang, Catherine H. Weldon, Wanwan Xu, Steven Pitts, Adam Auton, Noura S. Abul-Husn, Alison Chubb, R. Ryanne Wu
Effects of CYP3A4, CYP3A5, and ABCB1 genetic variants on tacrolimus metabolism during the early period after kidney transplantation
Nahathai Dukaew, Kajohnsak Noppakun, Mingkwan Na Takuathung, Nattharinee Kongta, Ratchanon Inpan, Naruemon Suyayai, Nut Koonrungsesomboon
Understanding public perspectives on direct-to-consumer pharmacogenomic testing in the UK: a qualitative study
Amy Mathieson, Lisa Brunton, Stephanie Gillibrand, Ramona Moldovan, John H. McDermott
Toxicity related to immunotherapy in urothelial cancer: Tumour genetic risk variants
JM Rodríguez-Piñas, A. Romero-Lorca, A. Novillo, M. Gaibar, M. Rubio, B. Antón-Pascual, S. Hernando, I. Alemany, FI Camacho, M. Cavanagh, M. Boiza, D. Marrupe, AM Martín, R. Khedaoui, A. Fernández-Santander
Frequently asked questions
How long does it take to publish?
Submission to first editorial decision (median days): 4. Submission to acceptance (median days): 283.
Reformat to The Pharmacogenomics Journal using Livewrite PremiumIs a cover letter required?
A cover letter is required and should include the corresponding author’s affiliation and contact information, the importance of the work, why it is appropriate for the journal’s readership, confirmation that the work is original, not previously published, and not under consideration elsewhere, prior reviewer comments if previously considered by another journal, and a competing interests statement.
Reformat to The Pharmacogenomics Journal using Livewrite PremiumWhat are the publication costs?
Open access publication requires an APC of £3190.00 / $5090.00 / €3990.00, subject to VAT or local taxes where applicable.
Reformat to The Pharmacogenomics Journal using Livewrite Premium